
Cambrium is a next-generation chemical manufacturer specializing in designing and producing high-performance molecules called Supermolecules™. These molecules are created using AI-driven molecular design technology that optimizes for improved performance and seamless integration with existing industrial processes. Cambrium manufactures these novel molecules using biotechnology, enabling the creation of innovative materials that are better for people and the planet. Their business model focuses on partnering with companies to solve material challenges by delivering superior molecular solutions, with manufacturing capabilities that utilize local feedstocks close to customers. They have demonstrated successful projects including outperforming polyurethanes, creating PVC alternatives, and producing natural retinol replacements and hair bonding solutions. Cambrium is positioned as a resilient manufacturer leveraging synthetic biology, machine learning, and lab automation to accelerate biomaterial innovation at scale.

Cambrium is a next-generation chemical manufacturer specializing in designing and producing high-performance molecules called Supermolecules™. These molecules are created using AI-driven molecular design technology that optimizes for improved performance and seamless integration with existing industrial processes. Cambrium manufactures these novel molecules using biotechnology, enabling the creation of innovative materials that are better for people and the planet. Their business model focuses on partnering with companies to solve material challenges by delivering superior molecular solutions, with manufacturing capabilities that utilize local feedstocks close to customers. They have demonstrated successful projects including outperforming polyurethanes, creating PVC alternatives, and producing natural retinol replacements and hair bonding solutions. Cambrium is positioned as a resilient manufacturer leveraging synthetic biology, machine learning, and lab automation to accelerate biomaterial innovation at scale.
Headquarters: Berlin, Germany
Founded: 2020
Primary offering: AI-designed protein-derived performance molecules ("Supermolecules") and biomaterial manufacturing
Notable product: NovaColl (designed collagen derivative for personal care)
Approx. employees: 26
| Company |
|---|
Sustainable biomaterials and advanced molecule design to replace or outperform conventional chemical and polymer solutions in personal care and materials markets.
2020
Biotechnology Research
€11 million (reported)
Reported seed raise to expand operations and structural-protein programs
$19 million (reported)
Reported Series A
“Multiple venture investors including Gradient, HOF Capital, Merantix Capital, Valor Equity Partners and others listed as participants”
What We Do Today, materials production accounts for 23% of GHG emissions and shows no sign of slowing down. Cambrium was founded under the belief that biology offers a better way. For material innovation in nature, biology turns to proteins. Over the past 4.3 billion years evolution has shaped proteins with every material property imaginable. From surfactants and hard surfaces, to gels and foams, to coatings and adhesives. We built our platform to speed up biology’s innovation cycle to make the materials the world needs in a timeline that matters. By programming proteins at scale, we create sustainable breakthrough materials for innovators across cosmetics, fashion and packaging.
We are an equal-opportunity employer and value diversity. We consider all applications equally regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, or gender identity. We strongly encourage individuals from groups traditionally underrepresented in tech to apply, and we can help with immigration.
Your profile
What We Offer In addition to a competitive salary, you can expect the following: